Collagen Type I - Analysis
Research News and Information

Saturday, November 21, 2009

[Biochemical markers of bone turnover. New aspect. An automated assay for measuring bone turnover markers]

30 Jul 2009 Recently, the measurement of biochemical bone turnover markers by automated immunoassay analyzer system was performed for the routine clinical laboratory tests in patients with osteoporosis and other metabolic bone diseases. Measurement of serum ... Read more...

[Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta]

30 Jul 2009 Osteogenesis imperfecta (OI) is a heterogeneous group of rare inherited bone and connective tissue disorders resulting from defect in collagen synthesis or function. It is characterized by bone fragility, which shows wide range of severities. The ... Read more...

Dynamic changes in bone metabolism in the rat temporomandibular joint after molar extraction using bone scintigraphy.

30 Jul 2009 Functional adaptation with reformation of bone tissue structure occurs after changes in mechanical stress distribution. To examine how occlusal changes affect the dynamics of bone metabolism in the mandibular condyle, bone scintigraphy of rat ... Read more...

Latest indexed articles for 'Collagen Type I - Analysis'

These are the very latest articles for this heading:

• [Biochemical markers of bone turnover. New aspect. An automated assay for measuring bone turnover markers] 30 Jul 2009
• [Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta] 30 Jul 2009
• Dynamic changes in bone metabolism in the rat temporomandibular joint after molar extraction using bone scintigraphy. 30 Jul 2009
• Characteristic changes of periodontal ligament-derived cells during passage. 30 Jul 2009
• High expression of HSP47 in ulcerative colitis-associated carcinomas: proteomic approach. 12 Jul 2009
• Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. 30 May 2009
• Comparison of calcium and silicate cement and mineral trioxide aggregate biologic effects and bone markers expression in MG63 cells. 29 Apr 2009
• Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production. 29 Apr 2009
• The outer wall of small airways is a major site of remodeling in fatal asthma. 8 Apr 2009
• Distribution of extracellular matrix components in normal and degenerated canine tricuspid valve leaflets. 30 Mar 2009
• [Effect of resveratrol on myocardial fibrosis in mice with chronic viral myocarditis] 30 Mar 2009
• Micro-CT analysis of alveolar bone healing using a rat experimental model of critical-size defects. 21 Mar 2009
• Cervical ripening and insufficiency: from biochemical and molecular studies to in vivo clinical examination. 18 Mar 2009
• Relationship between bone turnover and bone density at the proximal femur in stroke patients. 27 Feb 2009
• The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach. 27 Feb 2009
• Effect of risedronate in a minipig cartilage defect model with allograft. 27 Feb 2009
• Systemic MMP inhibition for periodontal wound repair: results of a multi-centre randomized-controlled clinical trial. 30 Jan 2009
• Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression. 30 Jan 2009
• Collagen content, but not the ratios of collagen type III/I mRNAs, differs among hypertensive, alcoholic, and idiopathic dilated cardiomyopathy. 29 Nov 2008
• The tendon-to-bone transition of the rotator cuff: a preliminary Raman spectroscopic study documenting the gradual mineralization across the insertion in rat tissue samples. 29 Nov 2008

See a longer list of these articles.

Technical information about 'Collagen Type I'

Definition: The most common form of fibrillar collagen. It is a major constituent of bone (BONE AND BONES) and SKIN and consists of a heterotrimer of two alpha1(I) and one alpha2(I) chains.

Registry Number: 0

Descriptor UI: D024042

Alternative terms: Collagen Type I; Type 1 Collagen; Collagen, Type 1; Type I Collagen; Collagen, Type I; Procollagen Type I; Type I Procollagen; Procollagen, Type I; Pro alpha 1 Collagen; Pro alpha 2 Collagen; Collagen Type I, alpha1 Subunit; alpha1 Type 1 Collagen; Collagen Type I, alpha1 Chain; Collagen alpha1(I); Collagen Type I, alpha2 Subunit; Collagen alpha2(I); alpha2 Type 1 Collagen; Collagen Type I, alpha2 Chain; alpha-2 Type 1 Collagen;

Related Mesh Headings: Osteogenesis Imperfecta;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D05.750.078.280.300.100; D12.776.860.300.250.300.100;

History Note: 2002; use COLLAGEN 1966-2001; for ALPHA-2 TYPE 1 COLLAGEN use COLLAGEN 1987-2001; for PROCOLLAGEN TYPE I use PROCOLLAGEN 1986-2001; for TYPE I PROCOLLAGEN & PRO ALPHA 2 COLLAGEN use PROCOLLAGEN 1982-2001; for PRO ALPHA 1 COLLAGEN use PROCOLLAGEN 1988-2001

Technical Notes: precursors: coord IM with PROCOLLAGEN (IM)